Synergistic Self‐Assembly of Natural Products to Modulate Gut Microbiota Metabolites for Enhancing Colorectal Cancer Therapy
Advanced Healthcare Materials · 2026-11-19
DOI: 10.1002/adhm.71995 ↗At a glance
Journal article in Advanced Healthcare Materials, published online on 2026-11-19. Written by Chengmei Xiao and 6 co-authors. 51 references. Funded by: Postdoctoral Innovation Project of Shandong Province, National Natural Science Foundation of China.
Abstract (original language)
The effective absorption of oral chemotherapy drugs in the intestines is of vital importance for enhancing their therapeutic effects. Natural plant‐derived compounds, in specific, their diversities in type, structure, and function, might offer opportunities to modulate gut microbiota metabolites for enhancing colorectal cancer therapy. Guided by this thinking, synergistic self‐assembly of natural products, namely Xyl‐CA/Sin nanoparticles (NPs), was engineered by integrating the prebiotic xylan (Xyl) with chlorogenic acid (CA) and sinomenine (Sin). Xyl protects the formulation during gastric transit and promotes targeted accumulation in colorectal tumors. Upon exposure to the acidic tumor microenvironment (TME), the NPs release CA and Sin, enabling their therapeutic actions. In colorectal cancer (CRC) models, CA triggers tumor cell pyroptosis, while Sin reshapes macrophage polarization and elevates the microbial tryptophan metabolite indole‐3‐acetic acid (3‐IAA). Acting synergistically, 3‐IAA and CA suppress glutathione peroxidase 3 (GPx3) and glutathione peroxidase 7 (GPx7), leading to reactive oxygen species (ROS) accumulation and autophagy inhibition. This cascade restrains tumor growth, induces immunogenic cell death (ICD), and stimulates antitumor immunity. Overall, this study presents a microbiota metabolite–driven strategy through the application of natural plant‐derived bioactive compounds to potentiate chemotherapy and establishes a concise, multimodal framework for antitumor therapy based on natural products.
Funding
- Postdoctoral Innovation Project of Shandong Province
- National Natural Science Foundation of China
Cite
APA
Xiao, C., Cao, Y., Wang, K., Wang, X., Zhao, X., Miao, Y., & Deng, D. (2026). Synergistic Self‐Assembly of Natural Products to Modulate Gut Microbiota Metabolites for Enhancing Colorectal Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71995
Vancouver
Xiao C, Cao Y, Wang K, Wang X, Zhao X, Miao Y, et al. Synergistic Self‐Assembly of Natural Products to Modulate Gut Microbiota Metabolites for Enhancing Colorectal Cancer Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71995
BibTeX
@article{Xiao2026,
author = {Xiao, Chengmei and Cao, Yuqi and Wang, Kaizhen and Wang, Xin and Zhao, Xiaomin and Miao, Yuhang and Deng, Dawei},
title = {Synergistic Self‐Assembly of Natural Products to Modulate Gut Microbiota Metabolites for Enhancing Colorectal Cancer Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71995}
}
EUVIMED